IBPI, AMRI in anti-infective deal

Under a two-year agreement, IntraBiotics (IBPI) will

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE